ResearcherParacelsus Medical UniversityNo recent work listed
Florian Hohla
Matched on OpenAlex author ID A5027169393. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 3
- Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients. First author DOI 10.2144/fsoa-2020-0128↗
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Co-author DOI 10.1016/s1470-2045(16)00172-8↗
- Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review. Co-author DOI 10.3892/ijo.2013.2176↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gabriel Rinnerthaler · 2 shared papers, 2014–2020 · strength 0.14
- Paper Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic … DOI 10.2144/fsoa-2020-0128↗
- Paper Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution … DOI 10.3892/ijo.2013.2176↗
- Stefan Stättner · 2 shared papers, 2014–2020 · strength 0.14
- Paper Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic … DOI 10.2144/fsoa-2020-0128↗
- Paper Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution … DOI 10.3892/ijo.2013.2176↗
- Richard Greil · 2 shared papers, 2014–2020 · strength 0.14
- Paper Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic … DOI 10.2144/fsoa-2020-0128↗
- Paper Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution … DOI 10.3892/ijo.2013.2176↗
- Konstantin Schlick · 1 shared paper, 2020 · strength 0.10
- Theodore Sunki Hong · 1 shared paper, 2016 · strength 0.04
- Jason Edward Faris · 1 shared paper, 2016 · strength 0.04
- Thierry Conroy · 1 shared paper, 2016 · strength 0.04
- Eric A. Mellon · 1 shared paper, 2016 · strength 0.04
- Ravi Shridhar · 1 shared paper, 2016 · strength 0.04
- Sing Yu Moorcraft · 1 shared paper, 2016 · strength 0.04
- Mustafa Suker · 1 shared paper, 2016 · strength 0.04
- Ian Chau · 1 shared paper, 2016 · strength 0.04
- Bas Groot Koerkamp · 1 shared paper, 2016 · strength 0.04
- Eran Sadot · 1 shared paper, 2016 · strength 0.04
- Lysiane Marthey · 1 shared paper, 2016 · strength 0.04
- Peter J. Hosein · 1 shared paper, 2016 · strength 0.04
- Peter J. Allen · 1 shared paper, 2016 · strength 0.04
- Casper H.J. van Eijck · 1 shared paper, 2016 · strength 0.04
- Julien Taı̈eb · 1 shared paper, 2016 · strength 0.04
- Jill Lacy · 1 shared paper, 2016 · strength 0.04
- Andrea Wang‐Gillam · 1 shared paper, 2016 · strength 0.04
- Bassel F. El‐Rayes · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.